Key result
GLP-1 and liraglutide reduce AF and prevent atrial remodeling in type 2 diabetic mice.
Why the study?
AF is highly prevalent and increases morbidity and mortality in T2DM, but the effects of GLP-1 receptor agonists on AF in T2DM are poorly understood.
Does GLP-1 or liraglutide reduce atrial fibrillation and prevent atrial remodeling in type 2 diabetic db/db mice?
Population
Type 2 diabetic db/db mice
Comparison
GLP-1 and liraglutide treatment
Design
Animal experimental study
Authors
Loading...
Should not change AF management in diabetes; leaves open translation of GLP-1 effects from mice to humans.
Does GLP-1 or liraglutide reduce atrial fibrillation and prevent atrial remodeling in type 2 diabetic db/db mice?
GLP-1 and liraglutide reduce atrial fibrillation susceptibility and prevent atrial remodeling in a mouse model of type 2 diabetes, suggesting a potential protective effect in humans.
Bohne et al. (2023) studied this question. GLP-1 and liraglutide reduced atrial fibrillation and prevented atrial remodeling in type 2 diabetic db/db mice.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: